Zhao, Z., li, W., & Long, H. (2014). Readministration of EGFR Tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients after Initial Failure, What Affects its Efficacy? Sci Rep.
Citação norma ChicagoZhao, Ze-Rui, Wei li, and Hao Long. "Readministration of EGFR Tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients After Initial Failure, What Affects Its Efficacy?" Sci Rep 2014.
ציטוט MLAZhao, Ze-Rui, Wei li, and Hao Long. "Readministration of EGFR Tyrosine Kinase Inhibitor in Non-small Cell Lung Cancer Patients After Initial Failure, What Affects Its Efficacy?" Sci Rep 2014.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.